Navigation Links
New Study Confirms Link Between Pain Pumps and Cartilage Damage -- Searcy Denney Law Firm Investigates Claims
Date:9/22/2008

South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) has stepped up its investigation into claims stemming from the use of pain pumps following a recent study confirming their dangers.

West Palm Beach, FL (PRWEB) September 22, 2008 -- South Florida law firm Searcy Denney Scarola Barnhart & Shipley PA (Searcy Denney) has stepped up its investigation into claims stemming from the use of pain pumps following a recent study confirming their dangers. According to the new study, the medication delivered by these pumps causes significant cartilage damage. This study confirms and explains earlier reports of adverse outcomes associated with pain pump use. The cartilage damage caused by these pumps results in a condition known as Post Arthroscopic Glenohumeral Chondrolysis (PAGCL), which can lead to significant pain, disability, repeat surgery and not infrequently, the necessity for total joint replacement.

Published in the American Journal of Sports Medicine and presented in July 2008 at this year's American Orthopedic Society for Sports Medicine meeting, the in vitro study measured the extent of cartilage damage caused by directly exposing cartilage to various concentrations and amounts of the pain medicines commonly used in these pumps. After seeing compelling evidence of cartilage destruction, the authors concluded the use of some medications should be discontinued. Others were recommended for use in minimal concentrations and for very short periods of time.

This study follows an earlier study finding pain pumps caused severe cartilage damage. Published by the American Journal of Sports Medicine (AJSM), the prior study found a strong association between the use of high volume pain pumps after arthroscopic surgery and a loss of cartilage in the shoulder. Doctors reviewed 177 shoulder cases and found a staggeringly high incidence of PAGCL in only those cases where intra-articular pain pumps were used.

We are now learning that these intra-articular pain pumps are being used after many types of joint surgery. Symptoms of joint damage include pain, increased stiffness, grinding or popping when the joint is in motion, decreased or limited range of movement and sometimes pain when the joint is at rest. If severe, the condition can progress to the point bone is rubbing on bone within the joint. The condition can be diagnosed through x-rays, which will show a narrowing of the space in the joint of the shoulder.

"Our clients as well as others are experiencing devastating complications from these pain pumps" said Cal Warner an attorney for Searcy Denney. "They often require numerous repeat surgeries and cannot work. Most concerning is the fact many of these patients are young athletes who face a lifetime of disability because the manufacturers failed to adequately test their products and instruct the medical community of the risk of complications."

The primary medical device manufacturers for the pumps include I-Flow, Inc., DJO Inc., BREG Inc., and Stryker Corporation.

Searcy Denney has set up a hotline to answer consumer questions about pain pump injuries. For more information, go to www.searcylaw.com.

About Searcy Denney Scarola Barnhart & Shipley, PA:
A nationally recognized trial law firm, Searcy Denney Scarola Barnhart & Shipley, P.A. is committed to protecting and vindicating the rights of people injured through negligence, deceit and abuse of power. Over the past 30 years, the firm has represented clients in courtrooms throughout Florida and across the nation.

For media interviews, contact Derede McAlpin at 202-973-1314.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1369724.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. UNC study: Parenting can override effect of genes in how babies respond to stress
2. Results From IMPROVE Study Show Therapeutic Effect of New Formulation of Rebif(R) at 16 Weeks in Patients With Multiple Sclerosis
3. Estrogen flooding our rivers, Université de Montréal study
4. Study suggests why heart attack victims do better with social support
5. Iowa State study finds moms beliefs may impact their kids alcohol use
6. Diabetes Spectrum Reports a Study Assessing the i-port(R) Injection Port for Administration of Insulin
7. Penn researchers use honeybee venom toxin to develop a new tool for studying hypertension
8. Mercks odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
9. Older problem gamblers may face greater suicide risk than younger counterparts, study finds
10. Colds and flu cut by one-third in study of Canadas top cold fighter in vaccinated seniors
11. Study offers new insights into teenagers and anxiety disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... Michael Lanteri Agency, an insurance ... Collins area, has unveiled a collaboration with nonprofit Big Bones Canine Rescue as ... worthy cause may now be made at http://bigbonescaninerescue.com/ . , Big Bones ...
(Date:3/23/2017)... ... March 23, 2017 , ... Altec Products, Inc. , ... as their 2016 Microsoft Dynamics Partner of the Year at DocLink Evolution ... award recognizes The Resource Group for their outstanding relationship with Altec and their ...
(Date:3/23/2017)... ... March 23, 2017 , ... Sharon Kleyne, host of ... Change and Your Health on VoiceAmerica, recently talked on her program about how she ... the occasion to remind listeners of an important distinction. World Water Day, Kleyne pointed ...
(Date:3/23/2017)... Kennett Square, PA (PRWEB) , ... March 23, 2017 , ... ... sunny days. That means many students are thinking about summer internships , which ... (or lack thereof). , The pros at Garden Media Group, a boutique public relations ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... The American ... 2017 marks the 40th Anniversary of ABQAURP’s dedication to Health Care Quality and Management ... who have contributed not only to the association, but also to the Health Care ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... SILVER SPRING, Md. , March 23, 2017 /PRNewswire-USNewswire/ ... approval to Bavencio (avelumab) for the treatment of adults ... Merkel cell carcinoma (MCC), including those who have not ... for metastatic MCC, a rare, aggressive form of skin ... the most common cancers, patients with a rare form ...
(Date:3/23/2017)... VANCOUVER, British Columbia , March 23, 2017 ... (the "Company" or "Sophiris"), a clinical late-stage biopharmaceutical company ... today announced that data from its successful Phase 2a ... focal treatment for localized prostate cancer, will be presented ... 32 nd Annual European Association of Urology in ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... offering. ... global oxygen therapy devices market to grow at a CAGR of ... Oxygen Therapy Devices Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
Breaking Medicine Technology: